114849636	114849636	CD	B-NP	O
|	|	NN	I-NP	O
SMH	SMH	NN	I-NP	O
|	|	NN	I-NP	O
07125258	07125258	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9679079	9679079	CD	B-NP	O
|	|	CC	I-NP	O
8/13/2003	8/13/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2003	10/10/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/23/2003	9/23/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ROYSDEN	ROYSDEN	NNP	B-NP	O
,	,	,	O	O
JIMMIE	JIMMIE	NNP	B-NP	O
337-13-52-4	337-13-52-4	CD	I-NP	O
Bay	Bay	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/13/03	6/13/03	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VOLKER	VOLKER	NNP	B-NP	O
,	,	,	O	O
RENALDO	RENALDO	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
2.5	2.5	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
Plavix	Plavix	NNP	B-NP	O
x	x	CC	O	O
90	90	CD	B-NP	O
days	day	NNS	I-NP	O
unless	unless	IN	B-SBAR	O
told	tell	VBN	B-VP	O
otherwise	otherwise	RB	B-ADVP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

PREVACID	PREVACID	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LANSOPRAZOLE	LANSOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HYDROCORTISONE	HYDROCORTISONE	NN	I-NP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
-	-	HYPH	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-ADVP	O
to	to	TO	B-VP	O
affected	affect	VBN	I-VP	O
eczematous	eczematous	JJ	B-NP	O
areas	area	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Thiara	Thiara	NNP	I-NP	O
June	June	NNP	I-NP	O
,	,	,	O	O
11AM	11AM	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Guinnip	Guinnip	NNP	I-NP	O
August	August	NNP	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cath	Cath	NNP	I-NP	O
:	:	:	O	O
Two	Two	CD	B-NP	O
vessel	vessel	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
Successful	Successful	JJ	I-NP	O
PTCA/Stenting	PTCA/Stenting	NN	I-NP	O
-	-	HYPH	O	O
Marg	Marg	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
to	to	TO	I-NP	O
0	0	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
drug	drug	NN	B-NP	O
eluting	elute	VBG	B-VP	O
stent	stent	JJ	B-NP	O
Successful	Successful	JJ	I-NP	O
Primary	Primary	JJ	I-NP	O
Stenting	Stenting	NN	I-NP	O
-	-	HYPH	B-NP	O
CX	CX	NN	I-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
bare	bare	JJ	B-NP	O
metal	metal	NN	I-NP	O
stent	stent	JJ	I-NP	O
Successful	Successful	JJ	I-NP	O
Angioplasty	Angioplasty	NNP	I-NP	O
-	-	HYPH	I-NP	O
distal	distal	JJ	I-NP	O
tru	tru	NN	I-NP	O
CX	CX	NN	I-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
Sheath	Sheath	NN	I-NP	O
Management	Management	NN	I-NP	O
-	-	HYPH	B-NP	O
Sutured	Suture	VBN	B-VP	O
in	in	IN	B-PP	O
site	site	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
groin	groin	NN	I-NP	O
-	-	HYPH	B-NP	O
RFA	RFA	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
:	:	:	O	O
Estimated	Estimate	VBN	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-NP	O
mild	mild	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
present	present	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
57	57	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
pk	pk	NN	I-NP	O
yr	yr	NN	I-NP	O
hx	hx	NN	I-NP	O
tob	tob	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
GERD	GERD	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
10/10	10/10	CD	I-NP	O
CP	CP	NN	I-NP	B-DNA
x	x	SYM	B-NP	O
36	36	CD	B-NP	O
hrs	hr	NNS	I-NP	O
.	.	.	O	O

CP	CP	NN	B-NP	O
burning	burning	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
ant	ant	JJ	I-NP	O
chest	chest	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
with	with	IN	B-PP	O
tingling	tingle	VBG	B-VP	O
feeling	feeling	NN	B-NP	O
to	to	TO	B-PP	O
neck	neck	NN	B-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
L	L	NN	B-NP	O
leg	leg	NN	I-NP	O
,	,	,	O	O
waxing	wax	VBG	B-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
over	over	IN	B-NP	O
1.5	1.5	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remembers	remember	VBZ	B-VP	O
having	have	VBG	I-VP	O
this	this	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
once	once	RB	B-ADVP	O
before	before	IN	B-PP	O
about	about	IN	B-NP	O
8	8	CD	I-NP	O
yrs	yr	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
as	as	IN	I-PP	O
severe	severe	JJ	B-ADJP	O
.	.	.	O	O

Walking	Walk	VBG	B-VP	O
made	make	VBN	B-NP	O
pain	pain	NN	I-NP	O
better	well	RBR	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
and	and	CC	I-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
PND	PND	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
claudication	claudication	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
ingestion	ingestion	NN	I-NP	O
or	or	CC	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
tachy	tachy	NN	I-NP	O
to	to	TO	B-PP	O
115	115	CD	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
144/85	144/85	CD	I-NP	I-DNA
,	,	,	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S4	S4	NN	B-NP	B-protein
.	.	.	O	O

weak	weak	JJ	B-NP	O
R	R	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
w	w	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
.	.	.	O	O

TnI	TnI	NN	B-NP	O
.82	.82	NN	I-NP	O
,	,	,	O	O
CKMB	CKMB	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
heparin	heparin	NN	B-NP	O
ggt	ggt	NN	I-NP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	O
,	,	,	O	O
ativan	ativan	NN	B-NP	O
,	,	,	O	O
MSO4	MSO4	NN	B-NP	B-protein
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
emergent	emergent	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
5/15/03	5/15/03	CD	B-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
or	or	CC	I-NP	O
LM	LM	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
proximal	proximal	JJ	B-NP	O
LCX	LCX	NN	I-NP	O
,	,	,	O	O
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bare	bare	JJ	I-NP	O
metal	metal	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OM1	OM1	NN	I-NP	B-DNA
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
drug	drug	NN	I-NP	O
eluting	elute	VBG	B-VP	O
stent	stent	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
post-procedure	post-procedure	JJ	I-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
or	or	CC	I-NP	O
bruit	bruit	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
artery	artery	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
insertion	insertion	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
mild	mild	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	I-NP	O
trace	trace	NN	I-NP	B-protein
TR	TR	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PRN	PRN	NN	B-NP	B-protein
NTG	NTG	NN	I-NP	I-protein
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
was	be	VBD	B-VP	O
total	total	JJ	B-NP	O
169	169	CD	I-NP	O
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
167	167	CD	B-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
43	43	CD	I-NP	I-DNA
,	,	,	O	O
cLDL	cLDL	NN	B-NP	O
93	93	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
?	?	.	O	O

angioedema	angioedema	NN	B-NP	O
to	to	TO	B-PP	O
ACE	ACE	NN	B-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
start	start	VB	I-VP	O
on	on	IN	B-PP	O
ARB	ARB	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
information	information	NN	B-NP	O
on	on	IN	B-PP	O
smoking	smoking	NN	B-NP	O
cessation	cessation	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
smoking	smoking	NN	I-NP	O
cessation	cessation	NN	I-NP	O
program	program	NN	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	O
was	be	VBD	B-VP	O
>	>	JJR	B-NP	O
300	300	CD	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
high	high	JJ	B-ADJP	O
off	off	IN	B-PP	O
her	her	PRP$	B-NP	O
metformin	metformin	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
HbA1c	HbA1c	NN	I-NP	B-protein
was	be	VBD	B-VP	O
13.2	13.2	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
DM	DM	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
some	some	DT	B-NP	O
DM	DM	NN	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
teaching	teaching	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
referral	referral	JJ	B-ADJP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Metformin	Metformin	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
IV	IV	CD	I-NP	O
contrast	contrast	NN	I-NP	O
during	during	IN	B-PP	O
cath	cath	NN	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
mucormist	mucormist	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
doses	dose	NNS	I-NP	O
afterwards	afterwards	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
hydration	hydration	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
0.8	0.8	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
without	without	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
or	or	CC	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Corolla	Corolla	NNP	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fainting	faint	VBG	B-VP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Petrucco	Petrucco	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Mayone	Mayone	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CORIELL	CORIELL	NNP	B-NP	O
,	,	,	O	O
HEATH	HEATH	NNP	B-NP	O
VAUGHN	VAUGHN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BA17	BA17	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/13/03	6/13/03	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

